Chronic Disease Management

The chronic disease management market encompasses consumers with chronic, complex conditions such as chronic kidney disease, diabetes, and heart disease. The challenges faced in this market are often compounded by the need for social services and supports. For provider organizations and health systems managing consumers with chronic conditions, a significant challenge that remains is addressing the rising cost of care for this population. As a result, payers are focusing on reducing the spend by increasing integrated models of care coordination across medical, behavioural, pharmacy, and social support systems. These new market forces are creating strategic opportunities for provider organizations that are serving this population.

Latest Resources

• Select Medical & Ballad Health Agree To Operate Joint Venture Critical Illness Recovery Hospital
• American Diabetes Association Announces Winners Of The Innovation Challenge To Transform Diabetes Care 
• CMS Proposes New Medicare Ambulatory Specialty Model To Improve Chronic Disease Management 
• Medicare & Medicaid Programs; CY 2026 Payment Policies Under The Physician Fee Schedule
• 18.6 Million People Living With Cancer In The United States  
• 1% Of U.S. Children Have Extremely Severe Obesity
• Nearly One-Third Of Adolescents Had Prediabetes In 2023 
• Dario Partners With GreenKey Health On A Value-Based Chronic Condition Management & Sleep Health Platform For Payers Nationwide 
• Connecticut State Employee Plan Pilot Of FlyteHealth Obesity Care Program Reports Savings In First Year Outcomes
• Home-Based Transcranial Direct Current Stimulation Reduced Fibromyalgia Pain More Than A Sham Treatment 
• Single-Dose Psilocybin Shows Lasting Mental Health Benefits For Those With Cancer 
• Jaan Health Secures $25 Million To Expand Its AI-Powered Platform Phamily To Support Between-Visit Care For Chronic Illness 
• New Framework For Cardiovascular Care Delivery & Implementation Calls For Incorporating Behavioral & Psychosocial Health 
• Cardiac Risk Factors Are Rising — But Many U.S. Adults Don’t Know They’re At Risk
• Prescriptions Of Anti-Obesity GLP-1 Medications For Adolescents Increased Between 2023 & 2024 

See All

Cardiac Risk Factors Are Rising — But Many U.S. Adults Don’t Know They’re At Risk

The proportion of adults in the United States who have one or more of three cardiac risk factors (hypertension, diabetes, and high cholesterol) increased between 2013 and 2023, but many affected people are unaware of their risks, according to a recent study. The lack of awareness was highest among those with hypertension, particularly among younger adults ages 20 to 44. The researchers stated that policy efforts to address these gaps in awareness are needed to… Read

• Virta Health Launches Cost Guarantees For Its Weight Loss & Diabetes Reversal Program, Promising 0% GLP-1 Utilization Trend & Guaranteed Weight Loss 
• Eden Launches Free Digital Wellness Community For Metabolic Wellness, Expanding Access To Personalized Fitness & Lifestyle Support 
• Death Rates From Alcohol-Associated Liver Disease Doubled From 1999 To 2022
• Consumption Of Ultraprocessed Foods May Cause More Than 14% Of Preventable Premature Deaths In The United States 
• LucyRx Partners With Personify Health On A Solution To Control Rising Employer GLP-1 Costs

To sign-up for monthly Chronic Disease Management alerts, you must be signed in to your account.